Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04866550
Status:
UNKNOWN
Last Update Posted:
2022-05-03
First Post:
2021-04-27
Brief Title:
Health in Smart Rurality Impact on Coordination of Care of Telemonitoring and Data Centralization of Frailty Patients
Sponsor:
Université de Reims Champagne-Ardenne
Organization:
Université de Reims Champagne-Ardenne
Study Overview
Official Title:
Health in Smart Rurality Impact on Coordination of Care of Telemonitoring and Data Centralization of Frailty Patients
Status:
UNKNOWN
Status Verified Date:
2022-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HIS2R
Brief Summary:
Chronic diseases are frequent around 10 of the total population and 30 after 60 years and accelerate age-related functional decline Concerning cross-border patients use of health services can be delayed given the distances the lack of rapid road access and the limited availability of public transport and the complex organization of coordinated care
One of the ways to reduce acute exacerbations and preserve the quality of life of patients is to detect warning signs early One of the ways to do this is to use new communication technologies
One of the ways to reduce acute exacerbations and preserve the quality of life of patients is to detect warning signs early One of the ways to do this is to use new communication technologies
Detailed Description:
The aim of the study is to assess feasibility of using a connected tablet to assess clinical parameters with an alert system in frailty patients aged over 60 living at home with heart failure and or chronic obstructive pulmonary disease potentially requiring care cross-border France and Belgium
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None